News NICE recommends cannabinoid med for severe epilepsy Global biopharma Jazz Pharmaceuticals’ Epidyolex/Epidiolex (cannabidiol), developed by GW Pharmaceuticals and now part of Jazz, has received
News Jazz agrees $7.2bn deal to buy cannabis meds pathfinder GW P... Jazz Pharma has agreed a $7.2 billion deal to by GW Pharmaceuticals and its pioneering cannabis-derived medicines, headed by childhood epilepsy drug Epidiolex.
News O'Shaughnessy says UK clinical trials sector is on the mend After losing ground in commercial clinical trials in recent years, the UK has now turned a corner and is once again taking a "global lead."
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
